Literature DB >> 12885677

What is the price of life and why doesn't it increase at the rate of inflation?

Peter A Ubel1, Richard A Hirth, Michael E Chernew, A Mark Fendrick.   

Abstract

Keywords:  Health Care and Public Health

Mesh：

Year:  2003        PMID： 12885677     DOI： 10.1001/archinte.163.14.1637

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN： 0003-9926


× No keyword cloud information.
  165 in total

1.  Effect of patient's life expectancy on the cost-effectiveness of treatment for ocular hypertension.

Authors:  Steven M Kymes; Michael R Plotzke; Michael A Kass; Michael V Boland; Mae O Gordon
Journal:  Arch Ophthalmol       Date:  2010-05

2.  How often do sensitivity analyses for economic parameters change cost-utility analysis conclusions?

Authors:  Bruce R Schackman; Heather Taffet Gold; Patricia W Stone; Peter J Neumann
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

3.  The cost of an additional disability-free life year for older Americans: 1992-2005.

Authors:  Liming Cai
Journal:  Health Serv Res       Date:  2012-06-07       Impact factor: 3.402

4.  Analyzing national health reform strategies with a dynamic simulation model.

Authors:  Bobby Milstein; Jack Homer; Gary Hirsch
Journal:  Am J Public Health       Date:  2010-03-18       Impact factor: 9.308

5.  Cost-effectiveness of adding an agent that improves immune responses to initial antiretroviral therapy (ART) in HIV-infected patients: guidance for drug development.

Authors:  Bethany L Morris; Callie A Scott; Timothy J Wilkin; Paul E Sax; Roy M Gulick; Kenneth A Freedberg; Bruce R Schackman
Journal:  HIV Clin Trials       Date:  2012 Jan-Feb

Review 6.  Cinacalcet: a pharmacoeconomic review of its use in secondary hyperparathyroidism in end-stage renal disease.

Authors:  Greg L Plosker
Journal:  Pharmacoeconomics       Date:  2011-09       Impact factor: 4.981

7.  The Irish Cost-Effectiveness Threshold: Does it Support Rational Rationing or Might it Lead to Unintended Harm to Ireland's Health System?

Authors:  James F O'Mahony; Diarmuid Coughlan
Journal:  Pharmacoeconomics       Date:  2016-01       Impact factor: 4.981

8.  Cost-Utility Analysis of Glaucoma Medication Adherence.

Authors:  Paula Anne Newman-Casey; Mariam Salman; Paul P Lee; Justin D Gatwood
Journal:  Ophthalmology       Date:  2019-10-10       Impact factor: 12.079

9.  Disease-modifying drugs for knee osteoarthritis: can they be cost-effective?

Authors:  E Losina; M E Daigle; L G Suter; D J Hunter; D H Solomon; R P Walensky; J M Jordan; S A Burbine; A D Paltiel; J N Katz
Journal:  Osteoarthritis Cartilage       Date:  2013-02-04       Impact factor: 6.576

10.  Cost-utility analysis of cataract surgery in Japan: a probabilistic Markov modeling study.

Authors:  Yoshimune Hiratsuka; Masakazu Yamada; Yoko Akune; Akira Murakami; Annabelle A Okada; Hidetoshi Yamashita; Yuichi Ohashi; Naoya Yamagishi; Hiroshi Tamura; Shunichi Fukuhara; Tomoyuki Takura
Journal:  Jpn J Ophthalmol       Date:  2013-04-16       Impact factor: 2.447
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.